Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1a+ dendritic cell phenotype

Archives of Dermatological Research

Volumn 293, Issue 3, 2001, Pages 147-158

  Hulette, B C ^a   Rowden, Geoffrey ^b   Ryan, Cindy A ^a   Lawson, Cathy M ^a   Dawes, Susan M ^a   Ridder, Gregg M ^a   Gerberick, G F ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Dendritic cells; KG 1; Langerhans cells

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; CELL STRUCTURE; CONTACT DERMATITIS; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; LANGERHANS CELL; LEUKEMIA CELL LINE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SKIN ALLERGY; UMBILICAL CORD BLOOD;

ANTIGENS, CD1; CYTOKINES; DENDRITIC CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0035084710     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030000201     Document Type: Article

References (43)

1. GM-CSF and TNF-a cooperate in the generation of dendritic Langerhans cells
2. Recent advances in the study of dendritic cells and follicular dendritic cells
3. Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naïve CD4+ T cells and process soluble antigen
4. Respective involvement of TGF-β and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors
5. Peptide-pulsed dendritic cells induce antigen-specific. CTL-mediated protective tumor immunity
6. CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells
7. Priming to mycobacterial antigen in vivo using antigen pulsed antigen presenting cells generated in vitro is influenced by the dose and presence of IL-4 in APC cultures
8. Reactivity of Langerhans cells with hybridoma antibody
9. Langerhans cells in human contact dermatitis contain varying numbers of Birbeck granules. Double staining immunohistochemistry with OKT6 and Lag antibody
10. Dendritic cells in antitumor immune responses
11. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells
12. Functional relevance of CD40 expression in human epidermis
13. Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed T lymphocytes
14. A monoclonal antibody specifically reactive to human Langerhans cells
15. Epidermal Langerhans cells are derived from cells originating in the bone marrow
16. Langerhans cell migration and cellular interactions
17. Epidermal Langerhans cells express Ia antigens
18. Acute myelogenous leukemia: A human cell line responsive to colony stimulating activity
19. Human myeloid leukemia cell lines: A review
20. CD34: Structure, biology, and clinical utility
21. Ueber die nerven der meuschlichen haut
22. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity
23. Functional human epidermal Langerhans cells that lack Birbeck granules
24. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte conditioned medium
25. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics
26. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood
27. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells
28. Ia antigen expression on human epidermal Langerhans cells
29. Histiocytosis X and non-X skin conditions distinguished by anti-S100 protein stain affinity
30. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages
31. Dendritic cells from mouse bone marrow: In vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor
32. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro
33. The dendritic cells system and its role in immunogenicity
34. The epidermis: An immunologic microenvironment
35. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model
36. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors
37. Flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum free conditions
38. Generation of human dendritic/Langerhans cells from circulating CD34+ hematopoietic progenitor cells
39. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells
40. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface
41. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells
42. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily
43. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation and T helper cell 1-associated cytokines